−9.68 MDKK
3.23 MDKK
61.55 M
About BRAIN+ A/S
Sector
Industry
CEO
Kim Baden-Kristensen
Website
Headquarters
Copenhagen
Founded
2012
ISIN
DK0061670205
FIGI
BBG01H311FX4
Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. It is involved in digital therapeutics that can be used independently or in combination with traditional medications, devices, and other therapies to optimize patient care and health outcomes. The company was founded by Kim Baden-Kristensen, Ulrik Ditlev Eriksen, and Rasmus Højengaard on April 17, 2012 and is headquartered in Copenhagen, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BRAINP is 0.1400 DKK — it has increased by 8.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange BRAIN+ A/S stocks are traded under the ticker BRAINP.
BRAINP stock is 20.69% volatile and has beta coefficient of −0.23. Check out the list of the most volatile stocks — is BRAIN+ A/S there?
Yes, you can track BRAIN+ A/S financials in yearly and quarterly reports right on TradingView.
BRAINP stock has risen by 12.00% compared to the previous week, the month change is a 6.67% fall, over the last year BRAIN+ A/S has showed a 77.49% decrease.
No, BRAINP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BRAINP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRAIN+ A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRAIN+ A/S technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRAIN+ A/S stock shows the sell signal. See more of BRAIN+ A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.